EU-South Korea deal will remove barriers for devices sector
This article was originally published in RAJ Devices
The European Union and South Korea have agreed a free trade deal that would, among other things, remove nontariff barriers such as regulations and standards in the medical equipment and pharmaceutical sectors1,2.
You may also be interested in...
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.